Background Outbreaks of orally transmitted Trypanosoma cruzi continue to be reported in Brazil and are associated with a high mortality rate, mainly due to myocarditis. Methods This study is a detailed report on the disease progression of acute Chagas disease in 13 patients who were infected during two micro-outbreaks in two northeastern Brazilian towns. Clinical outcomes as well as EKG and ECHO results are described, both before and after benznidazole treatment. Results Fever and dyspnea were the most frequent symptoms observed. Other clinical findings included myalgia, periorbital edema, headache and systolic murmur. Two patients died of cardiac failure before receiving benznidazole treatment. EKG and ECHO findings frequently showed a disturbance in ventricular repolarization and pericardial effusion. Ventricular dysfunction (ejection fraction <55%) was present in 27.3% of patients. After treatment, EKG readings normalized in 91.7% of patients. Ventricular repolarization abnormalities persisted in 50% of the patients, while sinus bradycardia was observed in 18%. The systolic ejection fraction normalized in two out of three patients with initially depressed ventricular function, while pericardial effusion disappeared. Conclusions Myocarditis is frequently found and potentially severe in patients with acute Chagas disease. Benznidazole treatment may improve clinical symptoms, as well as EKG and ECHO findings.
References
[1]
World Health Organization (2002) Control of Chagas disease. World Health Organ Tech Rep Ser 1–109.
[2]
Dias JC, Machado EM, Fernandes AL, Vinhaes MC (2000) Esbo？o geral e perspectivas da doen？a de Chagas no Nordeste do Brasil. Cad Saude Publica 16: 13–34. doi: 10.1590/s0102-311x2000000800003
[3]
Aras R, Veiga M, Gomes I, Mota G, Rodrigues B, et al. (2002) Prevalence of Chagas' disease in Mulungu do Morro northeastern Brazil. Arq Bras Cardiol 78: 441–443. doi: 10.1590/S0066-782X2002000500001
[4]
Prata A (2001) Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 1: 92–100. doi: 10.1016/S1473-3099(01)00065-2
[5]
Brasil , Ministério da Saúde , Secretaria de Vigilancia da Saúde (2005) Doen？a de Chagas aguda no município de Santana - Amapá. Technical Note. Available: http://www.parasitologia.org.br/default.？asp?MENU=20&EDITORIA=53. Accessed 2009 Jan 10.
[6]
Brasil , Ministério da Saúde , Secretaria de Vigilancia da Saúde (2005) Doen？a de Chagas Aguda relacionada à ingest？o de caldo de cana em Santa Catarina. Technical Note. Available: http://www.anvisa.gov.br/divulga/noticia？s/2005/240305_nota.pdf. Accessed 2009 Jan 3.
[7]
Brasil , Ministério da Saúde , Secretaria de Vigilancia da Saúde (2007) Doen？a de Chagas aguda por transmiss？o oral. Technical Note. Available: http://portal.saude.gov.br/portal/arquiv？os/pdf/nota_chagas2308.pdf. Accessed 2009 Jan15.
[8]
Dias JP, Bastos C, Araujo E, Mascarenhas AV, Martins Netto E, et al. (2008) Acute Chagas disease outbreak associated with oral transmission. Rev Soc Bras Med Trop 41: 296–300. doi: 10.1590/S0037-86822008000300014
[9]
Brasil , Ministério da Saúde , Secretaria de Vigilancia em Saúde (2005) Consenso Brasileiro em Doen？a de Chagas. Rev Soc Bras Med Trop 38: 1–29. doi: 10.1590/s0037-86821988000100006
[10]
Guimar？es FN, da Silva NN, Clausell DT, de Mello AL, Rapone T, et al. (1968) Um surto epidêmico de doen？a de Chagas de provável transmiss？o digestiva, ocorrido em Teut？nia (Estrela Rio Grande Do Sul). Hospital (Rio J) 73: 1767–1804.
[11]
Pinto AY, Harada GS, Valente V, Abud JE, Gomes F, et al. (2001) Acometimento cardíaco em pacientes com doen？a de Chagas aguda em microepidemia familiar, em Abaetetuba, na Amaz？nia Brasileira. Rev Soc Bras Med Trop 34: 413–419. doi: 10.1590/S0037-86822001000500003
[12]
Pinto AY, Valente SA, Valente VC (2004) Emerging acute Chagas disease in Amazonian Brazil: case reports with serious cardiac involvement. Braz J Infect Dis 8: 454–460. doi: /S1413-86702004000600010
[13]
Shikanai-Yasuda MA, Marcondes CB, Guedes LA, Siqueira GS, Barone AA, et al. (1991) Possible oral transmission of acute Chagas' disease in Brazil. Rev Inst Med Trop Sao Paulo 33: 351–357. doi: 10.1590/S0036-46651991000500003
[14]
Valente SA, da Costa Valente V, das Neves Pinto AY, de Jesus Barbosa Cesar M, dos Santos MP, et al. (2009) Analysis of an acute Chagas disease outbreak in the Brazilian Amazon: human cases, triatomines, reservoir mammals and parasites. Trans R Soc Trop Med Hyg 103: 291–297. doi: 10.1016/j.trstmh.2008.10.047
[15]
Anez N, Carrasco H, Parada H, Crisante G, Rojas A, et al. (1999) Acute Chagas' disease in Western Venezuela: a clinical, seroparasitologic, and epidemiologic study. Am J Trop Med Hyg 60: 215–222.
[16]
Carme B, Aune I, Nguyen G, Aznar C, Beaudet B (2001) Four cases of acute chagasic myocarditis in French Guiana. Am J Trop Med Hyg 64: 162–163.
[17]
Punukollu G, Gowda RM, Khan IA, Navarro VS, Vasavada BC (2007) Clinical aspects of the Chagas' heart disease. Int J Cardiol 115: 279–283. doi: 10.1016/j.ijcard.2006.03.004
[18]
Acquatella H (2007) Echocardiography in Chagas heart disease. Circulation 115: 1124–1131. doi: 10.1161/CIRCULATIONAHA.106.627323
[19]
Benchimol-Barbosa PR (2009) Predictors of mortality in Chagas' disease: the impact of atrial fibrillation and oral transmission on infected population. Int J Cardiol 133: 275–277. doi: 10.1016/j.ijcard.2007.11.053
[20]
Houghton RL, Benson DR, Reynolds LD, McNeill PD, Sleath PR, et al. (1999) A multi-epitope synthetic peptide and recombinant protein for the detection of antibodies to Trypanosoma cruzi in radioimmunoprecipitation-confirmed and consensus-positive sera. J Infect Dis 179: 1226–1234. doi: 10.1086/314723
[21]
Surawicz B, Childers R, Deal BJ, Gettes LS (2009) AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 53: 976–981. doi: 10.1016/j.jacc.2008.12.013
[22]
Pastore CA, Pinho C, Germiniani H, Samesima N, Mano R, et al. (2009) Diretrizes da Sociedade Brasileira de Cardiologia sobre Análise e Emiss？o de Laudos Eletrocardiográficos. Arq Bras Cardiol 93: 1–19. doi: 10.1590/S0066-782X2009000700001
[23]
Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, et al. (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 48: e1–e148. doi: 10.1016/j.jacc.2006.05.021
[24]
Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, et al. (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18: 1440–1463. doi: 10.1016/j.echo.2005.10.005
[25]
Coura JR (2007) Chagas disease: what is known and what is needed–a background article. Mem Inst Oswaldo Cruz 102: 113–122. doi: 10.1590/s0074-02762007000900018
[26]
Pinto AYN, Ferreira AG, Valente VC, Harada GS, Valente SAS (2009) Urban outbreak of acute Chagas disease in Amazon region of Brazil: four-year follow-up after treatment with benznidazole. Rev Panam Salud Publica 25: 77–83. doi: 10.1590/S1020-49892009000100012
[27]
Parada H, Carrasco HA, Anez N, Fuenmayor C, Inglessis I (1997) Cardiac involvement is a constant finding in acute Chagas' disease: a clinical, parasitological and histopathological study. Int J Cardiol 60: 49–54. doi: 10.1016/S0167-5273(97)02952-5
[28]
Hoft DF (1996) Differential mucosal infectivity of different life stages of Trypanosoma cruzi. Am J Trop Med Hyg 55: 360–364.
[29]
Hoft DF, Farrar PL, Kratz-Owens K, Shaffer D (1996) Gastric invasion by Trypanosoma cruzi and induction of protective mucosal immune responses. Infect Immun 64: 3800–3810.
[30]
Yoshida N (2008) Trypanosoma cruzi infection by oral route: how the interplay between parasite and host components modulates infectivity. Parasitol Int 57: 105–109. doi: 10.1016/j.parint.2007.12.008
[31]
Bilate AM, Teixeira PC, Ribeiro SP, Brito T, Silva AM, et al. (2008) Distinct outcomes of Trypanosoma cruzi infection in hamsters are related to myocardial parasitism, cytokine/chemokine gene expression, and protein expression profile. J Infect Dis 198: 614–623. doi: 10.1086/590347
[32]
de Andrade AL, Zicker F, de Oliveira RM, Almeida Silva S, Luquetti A, et al. (1996) Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 348: 1407–1413. doi: 10.1016/S0140-6736(96)04128-1
[33]
Sosa Estani S, Segura EL, Ruiz AM, Velazquez E, Porcel BM, et al. (1998) Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas' disease. Am J Trop Med Hyg 5: 526–529.
[34]
Viotti R, Vigliano C, Lococo B, Bertocchi G, Petti M, et al. (2006) Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med 144: 724–734. doi: 10.7326/0003-4819-144-10-200605160-00006
[35]
Rodrigues Coura J, de Castro SL (2002) A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 97: 3–24. doi: 10.1590/S0074-02762002000100001
[36]
Caldas IS, Talvani A, Caldas S, Carneiro CM, de Lana M, et al. (2008) Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions. Parasitol Res 103: 413–421. doi: 10.1007/s00436-008-0992-6
[37]
Cancado JR (2002) Long term evaluation of etiological treatment of Chagas disease with benznidazole. Rev Inst Med Trop Sao Paulo 44: 29–37. doi: 10.1590/S0036-46652002000100006
